2016 - Webinar on Effective Design Controls in Accordance with Subpart C of 21 CFR, Part 820

Description :
All industry professionals, regardless of functional roles, will benefit from this training, especially if you are involved in the day-to-day activities associated with your organization’s design and development process and/or sits on design and development teams.
The effective application of design control is one of the fundamental requirements needed in the design and development of medical devices that are safe and effective in their intended use. Additionally, the lack of effective design controls is one of the more frequently cited violations of the FDA’s Quality System Regulation. Not only is design control needed to support new product development, compliance with 820.30 is mandated by federal regulation.
Not only is an effective approach to design control mandated by regulatory requirements and necessary for the introduction of medical devices that are safe and effective into commerce; data collected during design and development will be needed to support regulatory submissions. Additionally, the FDA will visit your organization’s approach to design control, including the DHF and DMR during an agency inspection.
Areas Covered in the Session :
Effective Design and development planning
Clearly defining design inputs and outputs
The design review process
Design verification versus design validation
When does the design transfer
Design changes pre & post-design transfer
Maintenance of the Design History File (DHF)
The Device Master Record (DMR)
Who Will Benefit:
Quality Professionals
Regulatory Professionals
Design Engineers
Manufacturing Engineers
Project Managers